LAUSR

Abstract Since late December 2019, COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2, has spread rapidly around the world, causing unprecedented changes in provided health care services. Patients diagnosed with sleep-disordered breathing (SDB) are subject to a higher risk for worse outcomes from COVID-19, due to the high prevalence of coexistent comorbidities. Additionally, treatment with positive airway treatment devices (PAP) can also be challenging because of the greater transfer of PAP-induced droplets and aerosol. In this context, sleep medicine practices are entering a new era and need to adapt rapidly in these circumstances, so as to provide the best care for patients with SDB. Novel approaches like the application of telemedicine may play an important role in the management of patients with SDB during the COVID-19 pandemic.